Company
United StatesPublic company, NASDAQ: INGNInogen, Inc (NASDAQ: INGN), Goleta, CA – FDA Inspections
Inspection records and compliance data for Inogen, Inc in Goleta, California. 4 FDA inspections on record, last inspected November 03, 2022. Publicly traded as NASDAQ: INGN.
Company Profile
This profile covers Inogen, Inc based in Goleta, California, United States.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 0
- NAI
- 4
- Form 483s
- 0
- Warning letters
- 0
First inspected April 4, 2012. Last inspected November 3, 2022.
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 3, 2022 | NAI | Medical Devices & Rad Health · Compliance: Devices | 1191283 |
| March 3, 2016 | NAI | Medical Devices & Rad Health · Compliance: Devices | 965925 |
| April 17, 2014 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 875746 |
| April 4, 2012 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 777057 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Inogen, Inc
Stock ticker
INGN
Exchange
NASDAQ
Share price
$6.83
Market cap
$181.3M
Price as of
November 6, 2026
FEI Number
3004672275
Address
301 Coromar Dr, Goleta, California 93117, United States
Country
United States
ID: 4b72c052-a43d-406c-adbc-cd1c3376cce3